The Centers for Disease Control and Prevention is assisting in a multistate investigation on the use of contaminated non-sterile ultrasound gel for ultrasound-guided percutaneous procedures. Reports of Paraburkholderia fungorum detected in blood cultures from patients across multiple health care facilities prompted the investigation, and the CDC said it was aware of 40 confirmed cases of the bacteria in four states and two other countries as of May 8. Tests found at least two contaminated products under the MediChoice and ClearImage brands that are manufactured by NEXT Medical Products Company. The CDC provided a series of recommendations for health care providers to ensure patient safety and prevent potential outbreaks.

Headline
In a video on the AHA’s Care Delivery Transformation Framework, hospital leaders from CommonSpirit Health and Fairview Health Services share meaningful ways…
Headline
The AHA commented Feb. 9 on the Centers for Medicare & Medicaid Services’ proposed rule that would make changes to the Increasing Organ…
Blog
Despite medical advancements, maternal mortality rates have doubled since 1987. Yet more than 80% of pregnancy-related deaths have been deemed preventable.We…
Headline
The Centers for Medicare & Medicaid Services Dec. 9 issued a proposed rule that would make changes to the Increasing Organ Transplant Access Model…
Headline
The Centers for Medicare & Medicaid Services Dec. 2 repealed the minimum staffing requirements for nursing homes that participate in Medicare and Medicaid…
Headline
A blog by Michelle Schweitzer, executive director of advanced practice providers at WakeMed Health and Hospitals, and Dawn Mutchko, principal consultant at…